A Network Analysis on the Role of Specific ER Abilities as ERFs for Distress and Mental Health, in Relation to CAs Exposure in the AYAs
Launched by BABES-BOLYAI UNIVERSITY · May 22, 2025
Trial Information
Current as of July 06, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This clinical trial is studying how certain factors related to emotional resilience can affect stress and mental health in adolescents and young adults, especially those who have experienced childhood abuse. The goal is to understand how these factors interact and help young people manage distress. The study will look at participants aged 10 to 24 years old, with parental consent required for those under 18.
To be eligible, participants must not have any intellectual disabilities or physical limitations that would stop them from using the computer programs used in the study. The trial is not yet recruiting participants, but once it begins, those who take part can expect to share their experiences and perspectives on their emotional health. This research aims to improve understanding of mental health challenges among young people, which could lead to better support and resources for those in need.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adolescents and young adults between 10 and 24 years old provided with written parental consent where applicable
- Exclusion Criteria:
- • intellectual disability or physical limitations precluded the use of the computer program
About Babes Bolyai University
Babes-Bolyai University, a prestigious institution located in Cluj-Napoca, Romania, is dedicated to advancing research and innovation in various fields, including healthcare. With a strong emphasis on interdisciplinary collaboration, the university engages in cutting-edge clinical trials aimed at improving patient outcomes and enhancing medical knowledge. Leveraging a robust network of experts and state-of-the-art facilities, Babes-Bolyai University is committed to conducting high-quality research that adheres to ethical standards and contributes to the global scientific community. Through its clinical trial initiatives, the university seeks to foster advancements in treatment methodologies and promote evidence-based practices in medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cluj Napoca, Cluj, Romania
Patients applied
Trial Officials
Oana A. David, Ph.D
Principal Investigator
Babes-Bolyai University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported